ÂÜÀòÂÒÂ×

Rossitsa Vrabevska, Chief Medical Officer, MD, graduated from Medical University in Plovdiv, Bulgaria. After completing graduate courses (MSC) in Pharmacology at Massachusetts College of Pharmacy, Boston, USA, she gained pre-clinical and bioanalytical experience in the US (incl. Channing Laboratory, Harvard Medical School) and Japan. Joining Comac Medical in 2005, Dr. Vrabevska worked as Clinical Research Associate, Clinical Trial Manager, Director of Early Phase studies department in more than 100 clinical trials in Phase I/IIA and BA/BE. Currently, her responsibilities include oversight of the clinical development programs in Early Phase Trials, Scientific Advisory Group, Project Management and Quality.